Glucosides

"Glucosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

No definition found.

Descriptor ID	D005960
MeSH Number(s)	D09.408.348
Concept/Terms	Glucosides Glucosides

Below are MeSH descriptors whose meaning is more general than "Glucosides".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycosides [D09.408]
Glucosides [D09.408.348]

Below are MeSH descriptors whose meaning is related to "Glucosides".

Below are MeSH descriptors whose meaning is more specific than "Glucosides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glucosides" by people in this website by year, and whether "Glucosides" was a major or minor topic of these publications.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 3 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2007	0	1	1
2014	1	0	1
2017	1	1	2
2019	0	1	1
2020	1	2	3
2021	1	0	1
2024	0	1	1
2025	0	1	1
2026	1	0	1

Below are the most recent publications written about "Glucosides" by people in Profiles.

He W, Gu Y, Zhang F, Xiang Y, Fang Y, Cai J, Li W, Wang Z, Qin G, Li K, Gu X, Lin X, Ma L, Hou Y, Xiao X, Luo T. Polydatin Targets ACADVL to Combat Obesity by Promoting Adipocyte Browning and Activating Fatty Acid Oxidation. Phytother Res. 2026 May; 40(5):2417-2436.

View in: PubMed
Violari A, Otwombe K, Hahn W, Chen S, Josipovic D, Baba V, Angelidou A, Smolen KK, Levy O, Mkhize NN, Woodward Davis AS, Martin TM, Haynes BF, Williams WB, Sagawa ZK, Kublin JG, Polakowski L, Brewinski Isaacs M, Yen C, Tomaras G, Corey L, Janes H, Gray GE. Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns. J Clin Invest. 2025 Jun 02; 135(11).

View in: PubMed
Bhanushali KB, Asnani HK, Nair A, Ganatra S, Dani SS. Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials. Curr Probl Cardiol. 2024 Sep; 49(9):102664.

View in: PubMed
Isaza N, Calvachi P, Raber I, Liu CL, Bellows BK, Hernandez I, Shen C, Gavin MC, Garan AR, Kazi DS. Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction. JAMA Netw Open. 2021 07 01; 4(7):e2114501.

View in: PubMed
Dai C, Walker JT, Shostak A, Bouchi Y, Poffenberger G, Hart NJ, Jacobson DA, Calcutt MW, Bottino R, Greiner DL, Shultz LD, McGuinness OP, Dean ED, Powers AC. Dapagliflozin Does Not Directly Affect Human a or ? Cells. Endocrinology. 2020 08 01; 161(8).

View in: PubMed
Verma A, Patel AB, Waikar SS. SGLT2 Inhibitor: Not a Traditional Diuretic for Heart Failure. Cell Metab. 2020 07 07; 32(1):13-14.

View in: PubMed
Heyward J, Mansour O, Olson L, Singh S, Alexander GC. Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis. PLoS One. 2020; 15(6):e0234065.

View in: PubMed
Cheng C, Yu X, McClements DJ, Huang Q, Tang H, Yu K, Xiang X, Chen P, Wang X, Deng Q. Effect of flaxseed polyphenols on physical stability and oxidative stability of flaxseed oil-in-water nanoemulsions. Food Chem. 2019 Dec 15; 301:125207.

View in: PubMed
Coppenrath VA, Hydery T. Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2018 Jan; 52(1):78-85.

View in: PubMed
Abeyrathne PD, Grigorieff N. Expression, purification, and contaminant detection for structural studies of Ralstonia metallidurance ClC protein rm1. PLoS One. 2017; 12(7):e0180163.

View in: PubMed

People

Explore

Similar Concepts

Top Journals